aTyr Pharma Gains E.U. Patent Covering Use of Efzofitimod with Pirfenidone for Lung Inflammation or Fibrosis
January 19, 2023 08:00 ET
|
aTyr Pharma, Inc.
SAN DIEGO, Jan. 19, 2023 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary...
Ress Life Investments A/S: Ress Life Investments A/S publishes portfolio composition for Q4 2022
January 18, 2023 03:55 ET
|
Ress Life Investments A/S
Ress Life Investments A/SHolbergsgade 14, 2 tvDK-1057 Copenhagen KDenmarkCVR nr. 33593163resslifeinvestments.comTo: Nasdaq CopenhagenDate: 18 January 2023 Corporate Announcement 04/2023 Ress Life...
aTyr Pharma Announces LTBP1 as Target of DARS tRNA Synthetase Fragment
December 15, 2022 08:00 ET
|
aTyr Pharma, Inc.
LTBP1 is key regulator of TGF-β, a major driver of fibrosis. Latest target identified from company’s platform in collaboration with Dualsystems Biotech AG. SAN DIEGO, Dec. 15, 2022 (GLOBE...
Global Life Science Analytics Market Report to 2029 - Featuring Oracle, Accenture, SAS Institute, IBM and IQVIA Among Others
November 18, 2022 04:18 ET
|
Research and Markets
Dublin, Nov. 18, 2022 (GLOBE NEWSWIRE) -- The "Life Science Analytics Market Analysis by Component, by Type, by Application, by Delivery, by End User by Region - Global Forecast to 2029" report has...
Life Reinsurance Market Size In 2022 (New Report) | No. of pages: 115|: Manufacturers Data, Opportunity, Import Export Scenario, Application, Type, Regions and Future Forecast till 2028 with Top Growth Companies
November 16, 2022 02:12 ET
|
Proficient Market Insights
Pune, Nov. 16, 2022 (GLOBE NEWSWIRE) -- "Life Reinsurance Market" research report focus on overall information that can help to take decisions on current market situation. Reinsurance, also known as...
Southwestern Dean Emerita Susan Prager Receives Bernard E. Witkin Medal
November 10, 2022 18:00 ET
|
Southwestern Law School
San Diego & Los Angeles, California, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Southwestern Law School Dean Emerita Susan Westerberg Prager recently received the Bernard E. Witkin Medal, awarded...
aTyr Pharma Announces Third Quarter 2022 Results and Provides Corporate Update
November 10, 2022 16:00 ET
|
aTyr Pharma, Inc.
First patient dosed in Phase 3 EFZO-FIT™ study in patients with pulmonary sarcoidosis; multiple centers in the U.S. are open for enrollment. Company to prioritize resources towards largest value...
aTyr Pharma to Present at Upcoming Investor Conferences
November 10, 2022 08:00 ET
|
aTyr Pharma, Inc.
SAN DIEGO, Nov. 10, 2022 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary...
aTyr Pharma Announces Publication of Positive Data from Phase 1b/2a Clinical Study of Efzofitimod for the Treatment of Pulmonary Sarcoidosis in the Journal CHEST
November 09, 2022 08:00 ET
|
aTyr Pharma, Inc.
First therapy in sarcoidosis to reduce steroid burden while demonstrating improvements in key physiologic and quality of life measures. Global pivotal Phase 3 EFZO-FIT™ study currently enrolling. ...
New American Perspectives: Spotlight on Foreign-Born Filmmakers at HIFF
November 07, 2022 12:01 ET
|
The Vilcek Foundation
NEW YORK, Nov. 07, 2022 (GLOBE NEWSWIRE) -- The Vilcek Foundation will present the New American Perspectives program at the 42nd Annual Hawai'i International Film Festival (HIFF) in Honolulu this...